164 related articles for article (PubMed ID: 25743845)
21. CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth.
Kim TY; Jackson S; Xiong Y; Whitsett TG; Lobello JR; Weiss GJ; Tran NL; Bang YJ; Der CJ
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16868-73. PubMed ID: 24082123
[TBL] [Abstract][Full Text] [Related]
22. Tensin1 positively regulates RhoA activity through its interaction with DLC1.
Shih YP; Sun P; Wang A; Lo SH
Biochim Biophys Acta; 2015 Dec; 1853(12):3258-65. PubMed ID: 26427649
[TBL] [Abstract][Full Text] [Related]
23. The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity.
Basak P; Dillon R; Leslie H; Raouf A; Mowat MR
BMC Cancer; 2015 Sep; 15():630. PubMed ID: 26353792
[TBL] [Abstract][Full Text] [Related]
24. DLC1 as a regulator of proliferation, invasion, cell cycle, and apoptosis in cutaneous squamous cell carcinoma.
Yang C; Wu D; Jia J; Liu D; Li Z; Zhang C; Li M; Xia Y
Tumour Biol; 2013 Oct; 34(5):2633-43. PubMed ID: 23625658
[TBL] [Abstract][Full Text] [Related]
25. Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity.
Leung TH; Ching YP; Yam JW; Wong CM; Yau TO; Jin DY; Ng IO
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15207-12. PubMed ID: 16217026
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress induces proliferation of colorectal cancer cells by inhibiting RUNX3 and activating the Akt signaling pathway.
Kang KA; Kim KC; Bae SC; Hyun JW
Int J Oncol; 2013 Nov; 43(5):1511-6. PubMed ID: 24042352
[TBL] [Abstract][Full Text] [Related]
27. Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression.
Sánchez-Martín D; Otsuka A; Kabashima K; Ha T; Wang D; Qian X; Lowy DR; Tosato G
J Natl Cancer Inst; 2018 Apr; 110(4):390-399. PubMed ID: 29202196
[TBL] [Abstract][Full Text] [Related]
28. Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells.
Du X; Qian X; Papageorge A; Schetter AJ; Vass WC; Liu X; Braverman R; Robles AI; Lowy DR
Cancer Res; 2012 Sep; 72(17):4405-16. PubMed ID: 22693251
[TBL] [Abstract][Full Text] [Related]
29. Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression.
Yoon JH; Choi WS; Kim O; Choi BJ; Nam SW; Lee JY; Park WS
Gastric Cancer; 2017 Mar; 20(2):274-285. PubMed ID: 27250838
[TBL] [Abstract][Full Text] [Related]
30. Combination of dihydroartemisinin and resveratrol effectively inhibits cancer cell migration
Gao J; Ma F; Wang X; Li G
Food Funct; 2020 Nov; 11(11):9573-9584. PubMed ID: 33150340
[TBL] [Abstract][Full Text] [Related]
31. Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-Activating Proteins in Basal-like Breast Cancers.
Lawson CD; Fan C; Mitin N; Baker NM; George SD; Graham DM; Perou CM; Burridge K; Der CJ; Rossman KL
Cancer Res; 2016 Jul; 76(13):3826-37. PubMed ID: 27216196
[TBL] [Abstract][Full Text] [Related]
32. Restoration of DLC1 gene inhibits proliferation and migration of human colon cancer HT29 cells.
Wu PP; Jin YL; Shang YF; Jin Z; Wu P; Huang PL
Ann Clin Lab Sci; 2009; 39(3):263-9. PubMed ID: 19667410
[TBL] [Abstract][Full Text] [Related]
33. DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms.
Healy KD; Hodgson L; Kim TY; Shutes A; Maddileti S; Juliano RL; Hahn KM; Harden TK; Bang YJ; Der CJ
Mol Carcinog; 2008 May; 47(5):326-37. PubMed ID: 17932950
[TBL] [Abstract][Full Text] [Related]
34. Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1.
Li Y; Zhang Y; Liu X; Wang M; Wang P; Yang J; Zhang S
Int J Oncol; 2018 Jun; 52(6):2119-2129. PubMed ID: 29620169
[TBL] [Abstract][Full Text] [Related]
35. DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion.
Tripathi V; Popescu NC; Zimonjic DB
Oncogene; 2014 Feb; 33(6):724-33. PubMed ID: 23376848
[TBL] [Abstract][Full Text] [Related]
36. ARHGAP18 Downregulation by miR-200b Suppresses Metastasis of Triple-Negative Breast Cancer by Enhancing Activation of RhoA.
Humphries B; Wang Z; Li Y; Jhan JR; Jiang Y; Yang C
Cancer Res; 2017 Aug; 77(15):4051-4064. PubMed ID: 28619708
[TBL] [Abstract][Full Text] [Related]
37. Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD).
Sharma P; Kumar S
Cell Oncol (Dordr); 2018 Dec; 41(6):637-650. PubMed ID: 30088260
[TBL] [Abstract][Full Text] [Related]
38. Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer.
Gökmen-Polar Y; True JD; Vieth E; Gu Y; Gu X; Qi GD; Mosley AL; Badve SS
PLoS One; 2018; 13(10):e0204658. PubMed ID: 30278072
[TBL] [Abstract][Full Text] [Related]
39. A tumor suppressor DLC1: The functions and signal pathways.
Zhang Y; Li G
J Cell Physiol; 2020 Jun; 235(6):4999-5007. PubMed ID: 31773748
[TBL] [Abstract][Full Text] [Related]
40. ARHGAP24 inhibits cell proliferation and cell cycle progression and induces apoptosis of lung cancer via a STAT6-WWP2-p27 axis.
Wang L; Shen S; Xiao H; Ding F; Wang M; Li G; Hu F
Carcinogenesis; 2020 Jul; 41(5):711-721. PubMed ID: 31430374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
